カテゴリ： 世界, 医療/バイオ, QYResearch

細胞分裂タンパク質FtsZの世界市場2023年：Dardarin、LRRK2、EC2.7.11.1

■ 英語タイトル：Global Cell Division Protein FtsZ Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8717）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8717
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[細胞分裂タンパク質FtsZの世界市場2023年：Dardarin、LRRK2、EC2.7.11.1]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は細胞分裂タンパク質FtsZのグローバル市場について調査・分析し、世界の細胞分裂タンパク質FtsZ市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（Dardarin、LRRK2、EC2.7.11.1）、用途別セグメント分析（中枢神経系、循環器、消化器、腫瘍学、眼科）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Arrien Pharmaceuticals LLC、D. Western Therapeutics Institute Inc、Denali Therapeutics Inc、E-scape Bio Inc、Guangzhou DM Intelligence Ltd、H. Lundbeck AS、ICB International Inc、Imago Pharmaceuticals Inc、Ionis Pharmaceuticals Inc、Lead Discovery Center GmbH、Merck & Co Inc、Neuron23 Inc、Oncodesign SA、Shape Therapeutics Inc、Voronoi Groupなどが含まれています。細胞分裂タンパク質FtsZのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、細胞分裂タンパク質FtsZ市場規模を算出する際に考慮しました。

・細胞分裂タンパク質FtsZ市場の概要
- 製品の定義
- 細胞分裂タンパク質FtsZの種類別セグメント
- 世界の細胞分裂タンパク質FtsZ市場規模：タイプ別分析（Dardarin、LRRK2、EC2.7.11.1）
- 細胞分裂タンパク質FtsZの用途別セグメント
- 世界の細胞分裂タンパク質FtsZ市場規模：用途別分析（中枢神経系、循環器、消化器、腫瘍学、眼科）
- 世界の細胞分裂タンパク質FtsZ市場規模予測（2018年-2029年）
- 細胞分裂タンパク質FtsZの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 細胞分裂タンパク質FtsZ市場の競争状況およびトレンド

・細胞分裂タンパク質FtsZの地域別市場規模
- 北米の細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- 米国の細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- ヨーロッパの細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- アジア太平洋の細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- 中国の細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- 日本の細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- 韓国の細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- インドの細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- オーストラリアの細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- 中南米の細胞分裂タンパク質FtsZ市場規模（2018年-2029年）
- 中東・アフリカの細胞分裂タンパク質FtsZ市場規模（2018年-2029年）

・種類別セグメント：Dardarin、LRRK2、EC2.7.11.1
- 世界の細胞分裂タンパク質FtsZのタイプ別販売量（2018年-2023年）
- 世界の細胞分裂タンパク質FtsZのタイプ別売上（2018年-2023年）
- 世界の細胞分裂タンパク質FtsZのタイプ別価格

・用途別セグメント：中枢神経系、循環器、消化器、腫瘍学、眼科
- 世界の細胞分裂タンパク質FtsZの用途別販売量（2018年-2023年）
- 世界の細胞分裂タンパク質FtsZの用途別売上（2018年-2023年）
- 世界の細胞分裂タンパク質FtsZの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Arrien Pharmaceuticals LLC、D. Western Therapeutics Institute Inc、Denali Therapeutics Inc、E-scape Bio Inc、Guangzhou DM Intelligence Ltd、H. Lundbeck AS、ICB International Inc、Imago Pharmaceuticals Inc、Ionis Pharmaceuticals Inc、Lead Discovery Center GmbH、Merck & Co Inc、Neuron23 Inc、Oncodesign SA、Shape Therapeutics Inc、Voronoi Group

・産業チェーンと販売チャネルの分析
- 細胞分裂タンパク質FtsZ産業チェーン分析
- 細胞分裂タンパク質FtsZの主要原材料
- 細胞分裂タンパク質FtsZの販売チャネル
- 細胞分裂タンパク質FtsZのディストリビューター
- 細胞分裂タンパク質FtsZの主要顧客

・細胞分裂タンパク質FtsZ市場ダイナミクス
- 細胞分裂タンパク質FtsZの業界動向
- 細胞分裂タンパク質FtsZ市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) – Leucine-rich repeat kinase 2 (LRRK2) is an enzyme encoded by the PARK8 gene. It plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose 6 phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent manner together with RAB29. It regulates neuronal process morphology in the intact central nervous system. The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 3, 10 and 6 respectively. Similarly, the universities portfolio in Preclinical stages comprises 1 molecules, respectively. Report covers products from therapy areas Central Nervous System, Cardiovascular, Gastrointestinal, Oncology and Ophthalmology which include indications Parkinson’s Disease, Crohn’s Disease (Regional Enteritis), Glioblastoma Multiforme (GBM), Ocular Hypertension, Open-Angle Glaucoma, Pancreatic Cancer, Pulmonary Hypertension and Triple-Negative Breast Cancer (TNBC).
Highlights
The global Cell Division Protein FtsZ market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Cell Division Protein FtsZ is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cell Division Protein FtsZ is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Cell Division Protein FtsZ include Arrien Pharmaceuticals LLC, D. Western Therapeutics Institute Inc, Denali Therapeutics Inc, E-scape Bio Inc, Guangzhou DM Intelligence Ltd, H. Lundbeck AS, ICB International Inc, Imago Pharmaceuticals Inc and Ionis Pharmaceuticals Inc, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell Division Protein FtsZ, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Division Protein FtsZ.
The Cell Division Protein FtsZ market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Division Protein FtsZ market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Division Protein FtsZ manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Arrien Pharmaceuticals LLC
D. Western Therapeutics Institute Inc
Denali Therapeutics Inc
E-scape Bio Inc
Guangzhou DM Intelligence Ltd
H. Lundbeck AS
ICB International Inc
Imago Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Lead Discovery Center GmbH
Merck & Co Inc
Neuron23 Inc
Oncodesign SA
Shape Therapeutics Inc
Voronoi Group
Segment by Type
Dardarin
LRRK2
EC 2.7.11.1
Segment by Application
Central Nervous System
Cardiovascular
Gastrointestinal
Oncology
Ophthalmology
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cell Division Protein FtsZ manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cell Division Protein FtsZ in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Cell Division Protein FtsZ Market Overview
1.1 Product Overview and Scope of Cell Division Protein FtsZ
1.2 Cell Division Protein FtsZ Segment by Type
1.2.1 Global Cell Division Protein FtsZ Market Value Comparison by Type (2023-2029)
1.2.2 Dardarin
1.2.3 LRRK2
1.2.4 EC 2.7.11.1
1.3 Cell Division Protein FtsZ Segment by Application
1.3.1 Global Cell Division Protein FtsZ Market Value by Application: (2023-2029)
1.3.2 Central Nervous System
1.3.3 Cardiovascular
1.3.4 Gastrointestinal
1.3.5 Oncology
1.3.6 Ophthalmology
1.4 Global Cell Division Protein FtsZ Market Size Estimates and Forecasts
1.4.1 Global Cell Division Protein FtsZ Revenue 2018-2029
1.4.2 Global Cell Division Protein FtsZ Sales 2018-2029
1.4.3 Global Cell Division Protein FtsZ Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cell Division Protein FtsZ Market Competition by Manufacturers
2.1 Global Cell Division Protein FtsZ Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cell Division Protein FtsZ Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cell Division Protein FtsZ Average Price by Manufacturers (2018-2023)
2.4 Global Cell Division Protein FtsZ Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cell Division Protein FtsZ, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cell Division Protein FtsZ, Product Type & Application
2.7 Cell Division Protein FtsZ Market Competitive Situation and Trends
2.7.1 Cell Division Protein FtsZ Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cell Division Protein FtsZ Players Market Share by Revenue
2.7.3 Global Cell Division Protein FtsZ Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cell Division Protein FtsZ Retrospective Market Scenario by Region
3.1 Global Cell Division Protein FtsZ Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cell Division Protein FtsZ Global Cell Division Protein FtsZ Sales by Region: 2018-2029
3.2.1 Global Cell Division Protein FtsZ Sales by Region: 2018-2023
3.2.2 Global Cell Division Protein FtsZ Sales by Region: 2024-2029
3.3 Global Cell Division Protein FtsZ Global Cell Division Protein FtsZ Revenue by Region: 2018-2029
3.3.1 Global Cell Division Protein FtsZ Revenue by Region: 2018-2023
3.3.2 Global Cell Division Protein FtsZ Revenue by Region: 2024-2029
3.4 North America Cell Division Protein FtsZ Market Facts & Figures by Country
3.4.1 North America Cell Division Protein FtsZ Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cell Division Protein FtsZ Sales by Country (2018-2029)
3.4.3 North America Cell Division Protein FtsZ Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cell Division Protein FtsZ Market Facts & Figures by Country
3.5.1 Europe Cell Division Protein FtsZ Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cell Division Protein FtsZ Sales by Country (2018-2029)
3.5.3 Europe Cell Division Protein FtsZ Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cell Division Protein FtsZ Market Facts & Figures by Country
3.6.1 Asia Pacific Cell Division Protein FtsZ Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cell Division Protein FtsZ Sales by Country (2018-2029)
3.6.3 Asia Pacific Cell Division Protein FtsZ Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cell Division Protein FtsZ Market Facts & Figures by Country
3.7.1 Latin America Cell Division Protein FtsZ Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cell Division Protein FtsZ Sales by Country (2018-2029)
3.7.3 Latin America Cell Division Protein FtsZ Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cell Division Protein FtsZ Market Facts & Figures by Country
3.8.1 Middle East and Africa Cell Division Protein FtsZ Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cell Division Protein FtsZ Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cell Division Protein FtsZ Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cell Division Protein FtsZ Sales by Type (2018-2029)
4.1.1 Global Cell Division Protein FtsZ Sales by Type (2018-2023)
4.1.2 Global Cell Division Protein FtsZ Sales by Type (2024-2029)
4.1.3 Global Cell Division Protein FtsZ Sales Market Share by Type (2018-2029)
4.2 Global Cell Division Protein FtsZ Revenue by Type (2018-2029)
4.2.1 Global Cell Division Protein FtsZ Revenue by Type (2018-2023)
4.2.2 Global Cell Division Protein FtsZ Revenue by Type (2024-2029)
4.2.3 Global Cell Division Protein FtsZ Revenue Market Share by Type (2018-2029)
4.3 Global Cell Division Protein FtsZ Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cell Division Protein FtsZ Sales by Application (2018-2029)
5.1.1 Global Cell Division Protein FtsZ Sales by Application (2018-2023)
5.1.2 Global Cell Division Protein FtsZ Sales by Application (2024-2029)
5.1.3 Global Cell Division Protein FtsZ Sales Market Share by Application (2018-2029)
5.2 Global Cell Division Protein FtsZ Revenue by Application (2018-2029)
5.2.1 Global Cell Division Protein FtsZ Revenue by Application (2018-2023)
5.2.2 Global Cell Division Protein FtsZ Revenue by Application (2024-2029)
5.2.3 Global Cell Division Protein FtsZ Revenue Market Share by Application (2018-2029)
5.3 Global Cell Division Protein FtsZ Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Arrien Pharmaceuticals LLC
6.1.1 Arrien Pharmaceuticals LLC Corporation Information
6.1.2 Arrien Pharmaceuticals LLC Description and Business Overview
6.1.3 Arrien Pharmaceuticals LLC Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Arrien Pharmaceuticals LLC Cell Division Protein FtsZ Product Portfolio
6.1.5 Arrien Pharmaceuticals LLC Recent Developments/Updates
6.2 D. Western Therapeutics Institute Inc
6.2.1 D. Western Therapeutics Institute Inc Corporation Information
6.2.2 D. Western Therapeutics Institute Inc Description and Business Overview
6.2.3 D. Western Therapeutics Institute Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.2.4 D. Western Therapeutics Institute Inc Cell Division Protein FtsZ Product Portfolio
6.2.5 D. Western Therapeutics Institute Inc Recent Developments/Updates
6.3 Denali Therapeutics Inc
6.3.1 Denali Therapeutics Inc Corporation Information
6.3.2 Denali Therapeutics Inc Description and Business Overview
6.3.3 Denali Therapeutics Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Denali Therapeutics Inc Cell Division Protein FtsZ Product Portfolio
6.3.5 Denali Therapeutics Inc Recent Developments/Updates
6.4 E-scape Bio Inc
6.4.1 E-scape Bio Inc Corporation Information
6.4.2 E-scape Bio Inc Description and Business Overview
6.4.3 E-scape Bio Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.4.4 E-scape Bio Inc Cell Division Protein FtsZ Product Portfolio
6.4.5 E-scape Bio Inc Recent Developments/Updates
6.5 Guangzhou DM Intelligence Ltd
6.5.1 Guangzhou DM Intelligence Ltd Corporation Information
6.5.2 Guangzhou DM Intelligence Ltd Description and Business Overview
6.5.3 Guangzhou DM Intelligence Ltd Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Guangzhou DM Intelligence Ltd Cell Division Protein FtsZ Product Portfolio
6.5.5 Guangzhou DM Intelligence Ltd Recent Developments/Updates
6.6 H. Lundbeck AS
6.6.1 H. Lundbeck AS Corporation Information
6.6.2 H. Lundbeck AS Description and Business Overview
6.6.3 H. Lundbeck AS Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.6.4 H. Lundbeck AS Cell Division Protein FtsZ Product Portfolio
6.6.5 H. Lundbeck AS Recent Developments/Updates
6.7 ICB International Inc
6.6.1 ICB International Inc Corporation Information
6.6.2 ICB International Inc Description and Business Overview
6.6.3 ICB International Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ICB International Inc Cell Division Protein FtsZ Product Portfolio
6.7.5 ICB International Inc Recent Developments/Updates
6.8 Imago Pharmaceuticals Inc
6.8.1 Imago Pharmaceuticals Inc Corporation Information
6.8.2 Imago Pharmaceuticals Inc Description and Business Overview
6.8.3 Imago Pharmaceuticals Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Imago Pharmaceuticals Inc Cell Division Protein FtsZ Product Portfolio
6.8.5 Imago Pharmaceuticals Inc Recent Developments/Updates
6.9 Ionis Pharmaceuticals Inc
6.9.1 Ionis Pharmaceuticals Inc Corporation Information
6.9.2 Ionis Pharmaceuticals Inc Description and Business Overview
6.9.3 Ionis Pharmaceuticals Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ionis Pharmaceuticals Inc Cell Division Protein FtsZ Product Portfolio
6.9.5 Ionis Pharmaceuticals Inc Recent Developments/Updates
6.10 Lead Discovery Center GmbH
6.10.1 Lead Discovery Center GmbH Corporation Information
6.10.2 Lead Discovery Center GmbH Description and Business Overview
6.10.3 Lead Discovery Center GmbH Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Lead Discovery Center GmbH Cell Division Protein FtsZ Product Portfolio
6.10.5 Lead Discovery Center GmbH Recent Developments/Updates
6.11 Merck & Co Inc
6.11.1 Merck & Co Inc Corporation Information
6.11.2 Merck & Co Inc Cell Division Protein FtsZ Description and Business Overview
6.11.3 Merck & Co Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Merck & Co Inc Cell Division Protein FtsZ Product Portfolio
6.11.5 Merck & Co Inc Recent Developments/Updates
6.12 Neuron23 Inc
6.12.1 Neuron23 Inc Corporation Information
6.12.2 Neuron23 Inc Cell Division Protein FtsZ Description and Business Overview
6.12.3 Neuron23 Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Neuron23 Inc Cell Division Protein FtsZ Product Portfolio
6.12.5 Neuron23 Inc Recent Developments/Updates
6.13 Oncodesign SA
6.13.1 Oncodesign SA Corporation Information
6.13.2 Oncodesign SA Cell Division Protein FtsZ Description and Business Overview
6.13.3 Oncodesign SA Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Oncodesign SA Cell Division Protein FtsZ Product Portfolio
6.13.5 Oncodesign SA Recent Developments/Updates
6.14 Shape Therapeutics Inc
6.14.1 Shape Therapeutics Inc Corporation Information
6.14.2 Shape Therapeutics Inc Cell Division Protein FtsZ Description and Business Overview
6.14.3 Shape Therapeutics Inc Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Shape Therapeutics Inc Cell Division Protein FtsZ Product Portfolio
6.14.5 Shape Therapeutics Inc Recent Developments/Updates
6.15 Voronoi Group
6.15.1 Voronoi Group Corporation Information
6.15.2 Voronoi Group Cell Division Protein FtsZ Description and Business Overview
6.15.3 Voronoi Group Cell Division Protein FtsZ Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Voronoi Group Cell Division Protein FtsZ Product Portfolio
6.15.5 Voronoi Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cell Division Protein FtsZ Industry Chain Analysis
7.2 Cell Division Protein FtsZ Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cell Division Protein FtsZ Production Mode & Process
7.4 Cell Division Protein FtsZ Sales and Marketing
7.4.1 Cell Division Protein FtsZ Sales Channels
7.4.2 Cell Division Protein FtsZ Distributors
7.5 Cell Division Protein FtsZ Customers
8 Cell Division Protein FtsZ Market Dynamics
8.1 Cell Division Protein FtsZ Industry Trends
8.2 Cell Division Protein FtsZ Market Drivers
8.3 Cell Division Protein FtsZ Market Challenges
8.4 Cell Division Protein FtsZ Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Cell Division Protein FtsZ Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Cell Division Protein FtsZ Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Cell Division Protein FtsZ Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cell Division Protein FtsZ Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Cell Division Protein FtsZ Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Cell Division Protein FtsZ Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Cell Division Protein FtsZ Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Cell Division Protein FtsZ Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Cell Division Protein FtsZ, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Cell Division Protein FtsZ, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cell Division Protein FtsZ, Product Type & Application
Table 12. Global Key Manufacturers of Cell Division Protein FtsZ, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cell Division Protein FtsZ by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Division Protein FtsZ as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cell Division Protein FtsZ Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Cell Division Protein FtsZ Sales by Region (2018-2023) & (K Units)
Table 18. Global Cell Division Protein FtsZ Sales Market Share by Region (2018-2023)
Table 19. Global Cell Division Protein FtsZ Sales by Region (2024-2029) & (K Units)
Table 20. Global Cell Division Protein FtsZ Sales Market Share by Region (2024-2029)
Table 21. Global Cell Division Protein FtsZ Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Cell Division Protein FtsZ Revenue Market Share by Region (2018-2023)
Table 23. Global Cell Division Protein FtsZ Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Cell Division Protein FtsZ Revenue Market Share by Region (2024-2029)
Table 25. North America Cell Division Protein FtsZ Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Cell Division Protein FtsZ Sales by Country (2018-2023) & (K Units)
Table 27. North America Cell Division Protein FtsZ Sales by Country (2024-2029) & (K Units)
Table 28. North America Cell Division Protein FtsZ Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Cell Division Protein FtsZ Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Cell Division Protein FtsZ Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Cell Division Protein FtsZ Sales by Country (2018-2023) & (K Units)
Table 32. Europe Cell Division Protein FtsZ Sales by Country (2024-2029) & (K Units)
Table 33. Europe Cell Division Protein FtsZ Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Cell Division Protein FtsZ Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Cell Division Protein FtsZ Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Cell Division Protein FtsZ Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Cell Division Protein FtsZ Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Cell Division Protein FtsZ Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Cell Division Protein FtsZ Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cell Division Protein FtsZ Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Cell Division Protein FtsZ Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Cell Division Protein FtsZ Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Cell Division Protein FtsZ Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cell Division Protein FtsZ Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cell Division Protein FtsZ Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Cell Division Protein FtsZ Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Cell Division Protein FtsZ Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Cell Division Protein FtsZ Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cell Division Protein FtsZ Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Cell Division Protein FtsZ Sales (K Units) by Type (2018-2023)
Table 51. Global Cell Division Protein FtsZ Sales (K Units) by Type (2024-2029)
Table 52. Global Cell Division Protein FtsZ Sales Market Share by Type (2018-2023)
Table 53. Global Cell Division Protein FtsZ Sales Market Share by Type (2024-2029)
Table 54. Global Cell Division Protein FtsZ Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Cell Division Protein FtsZ Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Cell Division Protein FtsZ Revenue Market Share by Type (2018-2023)
Table 57. Global Cell Division Protein FtsZ Revenue Market Share by Type (2024-2029)
Table 58. Global Cell Division Protein FtsZ Price (US$/Unit) by Type (2018-2023)
Table 59. Global Cell Division Protein FtsZ Price (US$/Unit) by Type (2024-2029)
Table 60. Global Cell Division Protein FtsZ Sales (K Units) by Application (2018-2023)
Table 61. Global Cell Division Protein FtsZ Sales (K Units) by Application (2024-2029)
Table 62. Global Cell Division Protein FtsZ Sales Market Share by Application (2018-2023)
Table 63. Global Cell Division Protein FtsZ Sales Market Share by Application (2024-2029)
Table 64. Global Cell Division Protein FtsZ Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Cell Division Protein FtsZ Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Cell Division Protein FtsZ Revenue Market Share by Application (2018-2023)
Table 67. Global Cell Division Protein FtsZ Revenue Market Share by Application (2024-2029)
Table 68. Global Cell Division Protein FtsZ Price (US$/Unit) by Application (2018-2023)
Table 69. Global Cell Division Protein FtsZ Price (US$/Unit) by Application (2024-2029)
Table 70. Arrien Pharmaceuticals LLC Corporation Information
Table 71. Arrien Pharmaceuticals LLC Description and Business Overview
Table 72. Arrien Pharmaceuticals LLC Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Arrien Pharmaceuticals LLC Cell Division Protein FtsZ Product
Table 74. Arrien Pharmaceuticals LLC Recent Developments/Updates
Table 75. D. Western Therapeutics Institute Inc Corporation Information
Table 76. D. Western Therapeutics Institute Inc Description and Business Overview
Table 77. D. Western Therapeutics Institute Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. D. Western Therapeutics Institute Inc Cell Division Protein FtsZ Product
Table 79. D. Western Therapeutics Institute Inc Recent Developments/Updates
Table 80. Denali Therapeutics Inc Corporation Information
Table 81. Denali Therapeutics Inc Description and Business Overview
Table 82. Denali Therapeutics Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Denali Therapeutics Inc Cell Division Protein FtsZ Product
Table 84. Denali Therapeutics Inc Recent Developments/Updates
Table 85. E-scape Bio Inc Corporation Information
Table 86. E-scape Bio Inc Description and Business Overview
Table 87. E-scape Bio Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. E-scape Bio Inc Cell Division Protein FtsZ Product
Table 89. E-scape Bio Inc Recent Developments/Updates
Table 90. Guangzhou DM Intelligence Ltd Corporation Information
Table 91. Guangzhou DM Intelligence Ltd Description and Business Overview
Table 92. Guangzhou DM Intelligence Ltd Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Guangzhou DM Intelligence Ltd Cell Division Protein FtsZ Product
Table 94. Guangzhou DM Intelligence Ltd Recent Developments/Updates
Table 95. H. Lundbeck AS Corporation Information
Table 96. H. Lundbeck AS Description and Business Overview
Table 97. H. Lundbeck AS Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. H. Lundbeck AS Cell Division Protein FtsZ Product
Table 99. H. Lundbeck AS Recent Developments/Updates
Table 100. ICB International Inc Corporation Information
Table 101. ICB International Inc Description and Business Overview
Table 102. ICB International Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. ICB International Inc Cell Division Protein FtsZ Product
Table 104. ICB International Inc Recent Developments/Updates
Table 105. Imago Pharmaceuticals Inc Corporation Information
Table 106. Imago Pharmaceuticals Inc Description and Business Overview
Table 107. Imago Pharmaceuticals Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Imago Pharmaceuticals Inc Cell Division Protein FtsZ Product
Table 109. Imago Pharmaceuticals Inc Recent Developments/Updates
Table 110. Ionis Pharmaceuticals Inc Corporation Information
Table 111. Ionis Pharmaceuticals Inc Description and Business Overview
Table 112. Ionis Pharmaceuticals Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Ionis Pharmaceuticals Inc Cell Division Protein FtsZ Product
Table 114. Ionis Pharmaceuticals Inc Recent Developments/Updates
Table 115. Lead Discovery Center GmbH Corporation Information
Table 116. Lead Discovery Center GmbH Description and Business Overview
Table 117. Lead Discovery Center GmbH Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Lead Discovery Center GmbH Cell Division Protein FtsZ Product
Table 119. Lead Discovery Center GmbH Recent Developments/Updates
Table 120. Merck & Co Inc Corporation Information
Table 121. Merck & Co Inc Description and Business Overview
Table 122. Merck & Co Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Merck & Co Inc Cell Division Protein FtsZ Product
Table 124. Merck & Co Inc Recent Developments/Updates
Table 125. Neuron23 Inc Corporation Information
Table 126. Neuron23 Inc Description and Business Overview
Table 127. Neuron23 Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Neuron23 Inc Cell Division Protein FtsZ Product
Table 129. Neuron23 Inc Recent Developments/Updates
Table 130. Oncodesign SA Corporation Information
Table 131. Oncodesign SA Description and Business Overview
Table 132. Oncodesign SA Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Oncodesign SA Cell Division Protein FtsZ Product
Table 134. Oncodesign SA Recent Developments/Updates
Table 135. Shape Therapeutics Inc Corporation Information
Table 136. Shape Therapeutics Inc Description and Business Overview
Table 137. Shape Therapeutics Inc Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Shape Therapeutics Inc Cell Division Protein FtsZ Product
Table 139. Shape Therapeutics Inc Recent Developments/Updates
Table 140. Voronoi Group Corporation Information
Table 141. Voronoi Group Description and Business Overview
Table 142. Voronoi Group Cell Division Protein FtsZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Voronoi Group Cell Division Protein FtsZ Product
Table 144. Voronoi Group Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Cell Division Protein FtsZ Distributors List
Table 148. Cell Division Protein FtsZ Customers List
Table 149. Cell Division Protein FtsZ Market Trends
Table 150. Cell Division Protein FtsZ Market Drivers
Table 151. Cell Division Protein FtsZ Market Challenges
Table 152. Cell Division Protein FtsZ Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cell Division Protein FtsZ
Figure 2. Global Cell Division Protein FtsZ Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Cell Division Protein FtsZ Market Share by Type in 2022 & 2029
Figure 4. Dardarin Product Picture
Figure 5. LRRK2 Product Picture
Figure 6. EC 2.7.11.1 Product Picture
Figure 7. Global Cell Division Protein FtsZ Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Cell Division Protein FtsZ Market Share by Application in 2022 & 2029
Figure 9. Central Nervous System
Figure 10. Cardiovascular
Figure 11. Gastrointestinal
Figure 12. Oncology
Figure 13. Ophthalmology
Figure 14. Global Cell Division Protein FtsZ Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cell Division Protein FtsZ Market Size (2018-2029) & (US$ Million)
Figure 16. Global Cell Division Protein FtsZ Sales (2018-2029) & (K Units)
Figure 17. Global Cell Division Protein FtsZ Average Price (US$/Unit) & (2018-2029)
Figure 18. Cell Division Protein FtsZ Report Years Considered
Figure 19. Cell Division Protein FtsZ Sales Share by Manufacturers in 2022
Figure 20. Global Cell Division Protein FtsZ Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Cell Division Protein FtsZ Players: Market Share by Revenue in 2022
Figure 22. Cell Division Protein FtsZ Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Cell Division Protein FtsZ Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Cell Division Protein FtsZ Sales Market Share by Country (2018-2029)
Figure 25. North America Cell Division Protein FtsZ Revenue Market Share by Country (2018-2029)
Figure 26. United States Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Cell Division Protein FtsZ Sales Market Share by Country (2018-2029)
Figure 29. Europe Cell Division Protein FtsZ Revenue Market Share by Country (2018-2029)
Figure 30. Germany Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Cell Division Protein FtsZ Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Cell Division Protein FtsZ Revenue Market Share by Region (2018-2029)
Figure 37. China Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Cell Division Protein FtsZ Sales Market Share by Country (2018-2029)
Figure 47. Latin America Cell Division Protein FtsZ Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Cell Division Protein FtsZ Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Cell Division Protein FtsZ Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Cell Division Protein FtsZ Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Cell Division Protein FtsZ by Type (2018-2029)
Figure 57. Global Revenue Market Share of Cell Division Protein FtsZ by Type (2018-2029)
Figure 58. Global Cell Division Protein FtsZ Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Cell Division Protein FtsZ by Application (2018-2029)
Figure 60. Global Revenue Market Share of Cell Division Protein FtsZ by Application (2018-2029)
Figure 61. Global Cell Division Protein FtsZ Price (US$/Unit) by Application (2018-2029)
Figure 62. Cell Division Protein FtsZ Value Chain
Figure 63. Cell Division Protein FtsZ Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • タンパク質及びペプチド治療薬のグローバル市場展望 2023年-2029年：注射式、経口式
  • チロシンプロテインキナーゼマーの世界市場2023年：プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1
  • 細胞周期阻害剤の世界市場インサイト・予測（～2028年）
  • 受容体チロシンプロテインキナーゼERBB 3のグローバル市場展望 2023年-2029年：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他
  • CAR T細胞療法の世界市場2023年：CD19-対象、BCMA-対象
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8717 )"細胞分裂タンパク質FtsZの世界市場2023年：Dardarin、LRRK2、EC2.7.11.1" (英文：Global Cell Division Protein FtsZ Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。